Hidden Costs: The Clinical and Research Pitfalls of Mistaking Antidepressant Withdrawal for Relapse.
作者信息
Horowitz Mark A, Davies James
机构信息
Research and Development Department, North East London NHS Foundation Trust (NELFT), Rainham, UK.
Institute of Pharmaceutical Science, King's College London, London, UK.
出版信息
Psychother Psychosom. 2025;94(1):3-7. doi: 10.1159/000542437. Epub 2024 Nov 28.
Abstract
摘要
相似文献
1
Hidden Costs: The Clinical and Research Pitfalls of Mistaking Antidepressant Withdrawal for Relapse.隐性成本：将抗抑郁药撤药误认为复发的临床及研究陷阱
Psychother Psychosom. 2025;94(1):3-7. doi: 10.1159/000542437. Epub 2024 Nov 28.
2
Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults.成人抑郁和焦虑障碍中长效抗抑郁药停药与继续使用的方法。
Cochrane Database Syst Rev. 2021 Apr 15;4(4):CD013495. doi: 10.1002/14651858.CD013495.pub2.
3
Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT.在初级保健中使用抗抑郁药物预防抑郁症复发：ANTLER RCT。
Health Technol Assess. 2021 Nov;25(69):1-62. doi: 10.3310/hta25690.
4
Prophylactic effects or withdrawal reactions? An analysis of time-to-event data from antidepressant relapse prevention trials submitted to the FDA.预防效果还是撤药反应？对提交给美国食品药品监督管理局的抗抑郁药预防复发试验的事件发生时间数据的分析。
Ther Adv Psychopharmacol. 2021 Aug 10;11:20451253211032051. doi: 10.1177/20451253211032051. eCollection 2021.
5
How effective are antidepressants for depression over the long term? A critical review of relapse prevention trials and the issue of withdrawal confounding.从长期来看，抗抑郁药治疗抑郁症的效果如何？对预防复发试验及撤药混淆问题的批判性综述。
Ther Adv Psychopharmacol. 2020 May 8;10:2045125320921694. doi: 10.1177/2045125320921694. eCollection 2020.
6
Do withdrawal symptoms predict depression relapse after antidepressant cessation?戒断症状能否预测抗抑郁药停药后的抑郁症复发？
Eur Arch Psychiatry Clin Neurosci. 2025 Apr 23. doi: 10.1007/s00406-025-02005-z.
7
Outcome of antidepressant drug discontinuation with taperingstrips after 1-5 years.使用逐渐减量药条停药1至5年后抗抑郁药物的停药结果。
Ther Adv Psychopharmacol. 2020 Sep 2;10:2045125320954609. doi: 10.1177/2045125320954609. eCollection 2020.
8
Amygdala Reactivity, Antidepressant Discontinuation, and Relapse.杏仁核反应性、抗抑郁药停药和复发。
JAMA Psychiatry. 2024 Nov 1;81(11):1081-1089. doi: 10.1001/jamapsychiatry.2024.2136.
9
Withdrawal Confounding in Randomized Controlled Trials of Antipsychotic, Antidepressant, and Stimulant Drugs, 2000-2017.2000-2017 年抗精神病药、抗抑郁药和兴奋剂药物随机对照试验中的撤药混杂。
Psychother Psychosom. 2019;88(2):105-113. doi: 10.1159/000496734. Epub 2019 Mar 20.
10
Antidepressant discontinuation syndrome: A state-of-the-art clinical review.抗抑郁药停药综合征：最新临床综述。
Eur Neuropsychopharmacol. 2023 Jan;66:1-10. doi: 10.1016/j.euroneuro.2022.10.005. Epub 2022 Nov 4.
引用本文的文献
1
Post-acute withdrawal syndrome (PAWS) after stopping antidepressants: a systematic review with meta-narrative synthesis.停用抗抑郁药后的急性戒断后综合征（PAWS）：一项采用元叙事综合法的系统评价
Epidemiol Psychiatr Sci. 2025 May 13;34:e29. doi: 10.1017/S204579602500023X.
本文引用的文献
1
Incidence and risk factors of antidepressant withdrawal symptoms: a meta-analysis and systematic review.抗抑郁药戒断症状的发生率及危险因素：一项荟萃分析与系统评价
Mol Psychiatry. 2025 May;30(5):1758-1769. doi: 10.1038/s41380-024-02782-4. Epub 2024 Oct 11.
2
Incidence of antidepressant withdrawal symptoms.抗抑郁药戒断症状的发生率。
Lancet Psychiatry. 2024 Oct;11(10):788-789. doi: 10.1016/S2215-0366(24)00273-6.
3
Selective Serotonin Reuptake Inhibitor and Serotonin-Noradrenaline Reuptake Inhibitor Withdrawal Changes DSM Presentation of Mental Disorders: Results from the Diagnostic Clinical Interview for Drug Withdrawal.选择性 5-羟色胺再摄取抑制剂和 5-羟色胺-去甲肾上腺素再摄取抑制剂戒断改变 DSM 精神障碍表现：来自药物戒断诊断临床访谈的结果。
Psychother Psychosom. 2024;93(5):340-345. doi: 10.1159/000540031. Epub 2024 Jul 23.
4
Internet and Telephone Support for Discontinuing Long-Term Antidepressants: The REDUCE Cluster Randomized Trial.互联网和电话支持停用长期抗抑郁药：RE-DUCE 集群随机试验。
JAMA Netw Open. 2024 Jun 3;7(6):e2418383. doi: 10.1001/jamanetworkopen.2024.18383.
5
Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis.抗抑郁药停药症状的发生率：系统评价和荟萃分析。
Lancet Psychiatry. 2024 Jul;11(7):526-535. doi: 10.1016/S2215-0366(24)00133-0. Epub 2024 Jun 5.
6
Long-term consequences of benzodiazepine-induced neurological dysfunction: A survey.苯二氮䓬类药物引起的神经功能障碍的长期后果：一项调查。
PLoS One. 2023 Jun 29;18(6):e0285584. doi: 10.1371/journal.pone.0285584. eCollection 2023.
7
The need for antidepressant withdrawal support services: Recommendations from 708 patients.对抗抑郁药戒断支持服务的需求：708名患者的建议
Psychiatry Res. 2023 Aug;326:115303. doi: 10.1016/j.psychres.2023.115303. Epub 2023 Jun 22.
8
Discontinuation of Antidepressant Medications: A Significant Healthcare Problem Insufficiently Addressed by the NICE Guidelines.抗抑郁药物的停用：一个重要的医疗保健问题，英国国家卫生与临床优化研究所（NICE）指南对此处理不足。
Psychother Psychosom. 2023;92(3):148-151. doi: 10.1159/000530692. Epub 2023 May 24.
9
Designing withdrawal support services for antidepressant users: Patients' views on existing services and what they really need.为抗抑郁药使用者设计戒断支持服务：患者对现有服务的看法及他们真正的需求。
J Psychiatr Res. 2023 May;161:298-306. doi: 10.1016/j.jpsychires.2023.03.013. Epub 2023 Mar 20.
10
Enduring neurological sequelae of benzodiazepine use: an Internet survey.苯二氮䓬类药物使用的持久性神经后遗症：一项网络调查。
Ther Adv Psychopharmacol. 2023 Feb 6;13:20451253221145561. doi: 10.1177/20451253221145561. eCollection 2023.
Zotero 插件